The Effect of Omega 3 Supplements Comparison With Warm Compression in Patients With Dry Eye Disease

NCT06748768 | Active Not Recruiting DMC

• 1 other identifier: MSAHS/Batch-Spring23/043
• Study Type: observational
• Target: 140
• Locations: 1 country
• Sites: 1

Brief Summary

dry eye disease is a common condition characterized by tear film instability and ocular surface inflammation. Omega 3 fatty acid and hot compression are two common tratement for dry eye diseases

Conditions

Dry Eye

Outcome Measures

Primary Outcomes (1)

• OSDI

  The OSDI score was grouped as per the following: normal (0-12 points), mild (13-22 points), moderate (23-32 points), and severe (33-100 points) \[7\]. Grouping for the number of years smoking was done in the following way: \< 1 year, 1-5 years, 6-10 years, 11-15 years, 16-20 years, and 20+ years.

  12 Months

Interventions

group 1 DIAGNOSTIC_TEST

To determine the optimal treatment for dry eyes in term of cost effectiveness and time efficiency by comparing omega 3 supplements versus warm compression

Eligibility Criteria

• Age: 20 Years - 39 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)
• Sampling Method: Probability Sample

Study Population

to check the he Effect of Omega 3 Supplements Comparison With Warm Compression in Patients With Dry Eye Disease

You may qualify if:

• Young adults (20-39) years diagnosed with dry eyes and willingness to participate with no ocular surgery and infection from last 2 weeks Children

You may not qualify if:

• People having supplements
• Patients having diet with omega 3 for 1 month
• Patients who has undergone glaucoma treatment
• Already receiving treatment of dry eyes
• Patients with any ocular surgery

Sponsors & Collaborators

• Superior University: lead

Study Sites (1)

Benazir Bhutu Hospital

Rawalpindi, Punjab Province, Pakistan

Location

MeSH Terms

Conditions

Dry Eye Syndromes

Interventions

Chromosomes, Human, 1-3

Condition Hierarchy (Ancestors)

Lacrimal Apparatus Diseases; Eye Diseases

Intervention Hierarchy (Ancestors)

Chromosomes, Human; Chromosomes, Mammalian; Chromosomes; Genetic Structures; Genetic Phenomena

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: December 19, 2024
• First Posted: December 27, 2024
• Study Start: February 28, 2024
• Primary Completion: June 1, 2024
• Study Completion: February 1, 2025
• Last Updated: December 27, 2024

Record last verified: 2024-12

Data Sharing

• IPD Sharing: Will not share

Locations

PA (1)